Literature DB >> 8038754

Smooth muscle hypertrophy and arterial remodelling in deoxycorticosterone acetate-salt hypertension.

M D Ashen1, J M Hamlyn.   

Abstract

Morphometric analyses were made of medial-intimal cross-sectional area and lumen diameter in transverse sections of large arteries and small arterioles from normal and deoxycorticosterone acetate-salt hypertensive animals whose vasculatures were perfusion fixed at their in vivo mean arterial pressures. During the borderline and established phases of hypertension, changes in medial cross sectional area and lumen diameter were not detected in any vessel. During chronic mineralocorticoid hypertension, significant (p < 0.05) medial hypertrophy and an increased lumen diameter were found in the abdominal aorta whereas these parameters were normal in other large conduits, small arteries, and arterioles examined. These results indicate that medial hypertrophy is a late consequence of chronic hypertension in this model and is confined primarily to the abdominal aorta. Further, remodelling without medial hypertrophy may explain the normal lumen diameters of small arteries and arterioles in this model of hypertension.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8038754     DOI: 10.3109/10641969409072216

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  2 in total

1.  Low-dose ouabain constricts small arteries from ouabain-hypertensive rats: implications for sustained elevation of vascular resistance.

Authors:  Jin Zhang; John M Hamlyn; Eiji Karashima; Hema Raina; Joseph R H Mauban; Michelle Izuka; Roberto Berra-Romani; Alessandra Zulian; W Gil Wier; Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

2.  A novel method for comparison of arterial remodeling in hypertension: Quantification of arterial trees and recognition of remodeling patterns on histological sections.

Authors:  Alex A Gutsol; Paula Blanco; Svetlana I Samokhina; Sergey A Afanasiev; Chris R J Kennedy; Sergey V Popov; Kevin D Burns
Journal:  PLoS One       Date:  2019-05-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.